Medical Treatments For Patients With Advanced Prostate Cancer

In the United States, it’s estimated that roughly 1 in 5 men will be diagnosed with prostate cancer. According to the Surveillance, Epidemiology, and End Results program (SEER) of the National Cancer Institute, “the number of new cases of prostate cancer was 129.4 per 100,000 men per year. The number of deaths was 20.7 per 100,000 men per year. These rates are age-adjusted and based on 2009-2013 cases and

Radiotherapy, also called radiation therapy, is the treatment of cancer and other diseases with radiation. Radiotherapy is used when the entire primary tumor cannot be surgically removed. Radiotherapy deposits energy

One other treatment for lung cancer is radiation. Doctors can use radiation before surgery to shrink a tumor. After

Less than a third of men diagnosed with prostate cancer are still alive after five years

Radiation therapy is commonly used as a proven and widely accepted way to treat cancer. The American Cancer Society attests to this because of the extensive research they have done in this field. High-energy radiation damages a cell’s deoxyribonucleic acid (DNA). When a cell divides, its DNA splits. According to the Mayo Clinic, radiation therapy is sometimes given with curative intent (that is, with the hope that the treatment will cure cancer, either by eliminating a tumor, preventing cancer recurrence, or by both). In such cases, radiation therapy may be used alone or in combination with surgery, chemotherapy, or all three. Radiation therapy may also be given with palliative intent. Palliative treatments are not intended to cure. Instead, they are meant to relieve certain symptoms and reduce

The main objective is to strengthen the existing Prostate Cancer Support Group to encompass a broader community involvement. This will be achieved with the participation of professional speakers and a multidisciplinary team approach currently utilised in caring and supporting people with a life limiting illness.

Make this November about prostate cancer and raise awareness with “Movember.” Prostate cancer is one of the most common forms of men’s cancer, second to skin cancer. And it is also one of the leading causes of cancer death for men, according to the American Cancer Society. Making medical advice essential this Movember.

The final sample population of 303 beneficiaries received palliative radiation treatment in 2014 to bone metastases. Of those 303 beneficiaries, 24 beneficiaries (7.92%) had single-fraction treatments and 279 beneficiaries (92.1%) had multi-fraction treatments. The majority were 65-75 years of age (n=129; 42.6%) and 76-85 years of age (n=106; 35%). The mean age was 73.3 years, and the majority were Caucasian (n=276; 91.1%). The majority of all radiation treatments are in the Southeast (n=123; 40.6%) and gender was mostly balanced, with slightly more males than females. Overall, in our study the most common type of primary cancer to receive radiation for bone metastases are those with a primary diagnosis of lung cancer. Table 1 titled Demographic and Primary Malignancy Characteristics, provides a summary of the demographics.

This type of therapy is often used as a means to treat hyperthyroidism, thyroid cancer, bone metastases from prostate and breast tumors, as well as other types of cancer and diseases. It can be used alone or in combination with other therapeutic means of medicine, such as surgery or chemotherapy. Radiation therapy is used in the treatment of approximately 40% to 60% of patients who are diagnosed with cancer (Errors in Radiation Therapy, 2009). In many cases, the

Cancer, like other illnesses does not discriminate. It affects the rich and the poor and anyone who is susceptible to it. According to the American Cancer Society, millions of people are diagnosed each year. With these diagnostics, there are also many deaths. This is because some people do not respond to treatment or they come in too late. There have been some cases where there are no treatments or cures for the type of cancer as well. Cancer is like a plague and it has to be stopped and it takes the job of  radiation therapists and many other oncology specialists to come together to defeat it.

TREATMENT of localized prostate cancer usually includes prostatectomy and radiation therapy, occasionally augmented with hormonal therapies. However, Fu et al., (2012) have noted that recurrence of prostate cancer occurs in about 15% of patients within 5 years after prostatectomy and in about 40% patients within 10 years. Although, more than 70% of patients are expected to survive for more than 10 years after prostatectomy, radiation or hormone therapy, Cooperberg et al.,(2010) argued that localized prostate cancer patients with intermediate or high risk scores have higher mortality rate after these treatments. With chemotherapies as the existing treatment options for metastatic prostate cancers, patients are expected to have only a median survival of 12-15 months. Bono et al.,(2006). However, most of these traditional treatments are invasive and riddled with adverse side effects. Therefore, novel therapies are on high demand for the treatment of the malignant and recurrent forms of prostate cancer after these

Radiation and hormone therapy are commonly used as follow up treatments after a radical prostatectomy. A meta-analysis by Pinkawa (2010) reported that radiation doses of up to 76-87 Gy are effective in increasing survival in high-risk patients. Androgen deprivation hormone therapy is used to decrease male androgens such as testosterone (TST) and dihydrotestosterone (DHT) influencing proliferation of cancer cells in PCa. Multiple forms of hormone therapy exist, all sharing a common goal of reducing TST and DHT levels.

Prostate cancer is the most prevalent nonskin cancer among men in the United States and is the second leading cause of cancer death in men. While prostate cancer is most regularly diagnosed in men at the age of 65 years and older, the occurrence can begin at 50. One in 6 men will be diagnosed with prostate cancer during their lifetime. As researchers explore this form of cancer; men also need to know it’s essential to understand early prostate cancer is treatable. By these patients exploring these insights and investigating the lived experience of older men, it can provide a positive coping mechanisms.

Radiation therapy plays the same role as chemotherapy for as it destroys the cancer cells or shrinks the tumor through different radiation therapy; external beam radiation therapy, internal radiation therapy, and systemic radiation therapy. External radiation therapy is radiation from a machine is placed on the body to destroy the cancerous cells and internal radiation therapy is radioactive items placed on or near the tumor. Lastly systemic radiation therapy is radioactive items is swallowed or injected to destroy the cancerous cells. Immunotherapy helps by increasing your immune system to help fight off cancer for as it attacks when the immune system is down through monoclonal antibodies from proteins and cancer vaccines. Through these different medical treatments of therapy comes with side effects aside from the symptoms such as fatigue, loss of appetite, mouth sores, hair loss, low blood cell count, and more. But with your treatment there is assistance in therapies and specialist to help you manage to get through all these side effects as you go on to overcome leukemia. The prognosis

When we have diseases or don’t feel well, we tend to seek treatments and try to cure it as soon as possible. However, what if there is no reliable treatment or nearly no treatment available? Then, the only option is to do research. Life can be really difficult and no one wants any sickness or diagnosed with such a hard-to-cure disease like cancer. Prostate Cancer is a known cancer that happens to men only and a lot of men in the U.S are diagnosed with it, and happens to male’s reproductive system. Specifically speaking, it is a gland found in the most private area of a man. In the following paragraphs, I will be explaining why we need to find a way to combat prostate cancer, how to detect this cancer at early stages, and the risks associated with prostate cancer.